Literature DB >> 25820051

Comparing stress testing and fractional flow reserve to evaluate presence, location and extent of ischemia in coronary artery disease.

Deepak J Pattanshetty1, Pradeep K Bhat1, Sanjay Gandhi1, Dilip P Pillai1, Ashish Aneja2.   

Abstract

BACKGROUND: FFR provides an accurate and reproducible assessment of the functional severity of coronary stenosis. Whereas stress testing remains the preferred initial modality for assessment of ischemia, there is limited data comparing it with FFR. We sought to determine the correlation between cardiac stress testing and coronary fractional flow reserve (FFR) measurement for assessing the presence, location, and burden of myocardial ischemia in patients referred for evaluation of coronary artery disease (CAD).
METHODS: Over 5-year study period, of the 5420 consecutive coronary angiograms that were screened, 326 patients had FFR measurements. Of these, 96 patients with FFR measurements who had a preceding stress test (stress echocardiography [SE] or myocardial perfusion imaging [MPI]) within a year were included.
RESULTS: Of the 96 patients, there were 46 (48%) men and 50 (52%) women with a mean age of 61 ± 10 years. SE was performed in 57 (59.3%) and MPI in 32 (40.7%) of patients. FFR was ≤0.79 in 54 (56%) patients. Stress testing had low sensitivity (55%) and specificity (47%) compared to FFR. The concordance between FFR and stress testing was low for both presence (k=0.03) and location (k=0.05) of the ischemic territory. The number of ischemic vascular territories was correctly estimated in only 39% of the stress tests. SE was more likely to overestimate and MPI more likely to underestimate extent of ischemia.
CONCLUSIONS: In patients referred for evaluation of CAD, there was poor correlation between stress testing and FFR. A prospective study comparing these two modalities with FFR is needed.
Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac stress test; Coronary artery disease; Fraction flow reserve

Mesh:

Year:  2015        PMID: 25820051      PMCID: PMC4382543          DOI: 10.1016/j.ihj.2015.02.010

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  17 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.

Authors:  G J Bech; B De Bruyne; N H Pijls; E D de Muinck; J C Hoorntje; J Escaned; P R Stella; E Boersma; J Bartunek; J J Koolen; W Wijns
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

3.  Comparison of Tc-99m sestamibi SPECT with fractional flow reserve in patients with intermediate coronary artery stenoses.

Authors:  Marcus Hacker; Johannes Rieber; Rupert Schmid; Christian Lafougere; Andreas Tausig; Karl Theisen; Volker Klaus; Reinhold Tiling
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

4.  Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity of coronary arterial narrowing.

Authors:  J Bartunek; E Van Schuerbeeck; B de Bruyne
Journal:  Am J Cardiol       Date:  1997-02-15       Impact factor: 2.778

5.  Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease.

Authors:  S A Chamuleau; M Meuwissen; B L van Eck-Smit; K T Koch; A de Jong; R J de Winter; C E Schotborgh; M Bax; H J Verberne; J G Tijssen; J J Piek
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

6.  Meta-analysis of fractional flow reserve versus quantitative coronary angiography and noninvasive imaging for evaluation of myocardial ischemia.

Authors:  Maria A C Christou; George C M Siontis; Demosthenes G Katritsis; John P A Ioannidis
Journal:  Am J Cardiol       Date:  2006-12-20       Impact factor: 2.778

7.  Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis.

Authors:  Sachin M Navare; Jeff F Mather; Leslee J Shaw; Michael S Fowler; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

8.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

10.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses.

Authors:  N H Pijls; B De Bruyne; K Peels; P H Van Der Voort; H J Bonnier; J J Bartunek J Koolen; J J Koolen
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

View more
  1 in total

Review 1.  Fractional flow reserve to guide surgical coronary revascularization.

Authors:  Tara Shah; Joshua D Geleris; Ming Zhong; Rajesh V Swaminathan; Luke K Kim; Dmitriy N Feldman
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.